These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diabetic kidney disease: act now or pay later. Atkins RC; Zimmet P Acta Diabetol; 2010 Mar; 47(1):1-4. PubMed ID: 20099002 [No Abstract] [Full Text] [Related]
24. Diabetic kidney disease: act now or pay later. Atkins RC; Zimmet P J Hypertens; 2010 Feb; 28(2):408-10. PubMed ID: 20087106 [No Abstract] [Full Text] [Related]
25. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?]. Luño J; Valderrábano F An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851 [No Abstract] [Full Text] [Related]
26. Prevention of end-stage renal disease due to type 2 diabetes. Hostetter TH N Engl J Med; 2001 Sep; 345(12):910-2. PubMed ID: 11565525 [No Abstract] [Full Text] [Related]
27. Protein restriction and renal failure in diabetes mellitus. Parving HH N Engl J Med; 1991 Jun; 324(24):1743-4. PubMed ID: 2034255 [No Abstract] [Full Text] [Related]
28. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Parving HH Diabetologia; 1998 Jul; 41(7):745-59. PubMed ID: 9686914 [No Abstract] [Full Text] [Related]
30. [Low carbohydrate diet slowed down the progression of renal insufficiency in type 2 diabetes. A case--difficult to draw conclusions]. Vesti-Nielsen J; Westerlund P; Bygren P Lakartidningen; 2008 Jul 23-Aug 5; 105(30-31):2094-7. PubMed ID: 18751447 [No Abstract] [Full Text] [Related]
31. [Renal disease by type 2 diabetes]. Persson F; Rossing P Ugeskr Laeger; 2012 Sep; 174(37):2150-4. PubMed ID: 22971295 [TBL] [Abstract][Full Text] [Related]
32. Practical problems in the management of hypertension in the diabetic patient. O'Hare JP J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462 [No Abstract] [Full Text] [Related]
33. Preventing nephropathy in patients with type 2 diabetes. Manag Care Interface; 2002 Jan; 15(1):72-5. PubMed ID: 11828609 [No Abstract] [Full Text] [Related]
34. ACE inhibition in diabetic patients. Economic implications. Rodby RA; Lewis EJ Pharmacoeconomics; 1996 Oct; 10(4):315-20. PubMed ID: 10163576 [No Abstract] [Full Text] [Related]
35. Best practice for hypertensive patients with kidney disease. de Zeeuw D Hosp Med; 2003 Feb; 64(2):96-100. PubMed ID: 12619337 [TBL] [Abstract][Full Text] [Related]
37. Diabetic nephropathy--the family physician's role. Roett MA; Liegl S; Jabbarpour Y Am Fam Physician; 2012 May; 85(9):883-9. PubMed ID: 22612183 [TBL] [Abstract][Full Text] [Related]
38. [Milestone studies provide evidence: sartans have a nephroprotective effect. Evidence is clear]. Bold KO MMW Fortschr Med; 2001 May; 143(22):12-3. PubMed ID: 11460392 [No Abstract] [Full Text] [Related]
39. [Increasing number of dialysis-requiring patients with diabetic nephropathies. Better diabetes control and antihypertensive treatment can counteract the trend]. Kurkus J; Schön S; Prütz KG; Torffvit O Lakartidningen; 2005 May 2-15; 102(18-19):1420-3. PubMed ID: 15929425 [No Abstract] [Full Text] [Related]